Catalyst
Slingshot members are tracking this event:
Pain Therapeutics (PTIE) Announces Plans for Resubmission of NDA to FDA for Pain Medication REMOXY ER
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PTIE |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 21, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Resubmission, Nda, Pain Medication, Remoxy Er, New Drug Application